MANUFACTURING RIGHTS AGREEMENTManufacturing Rights Agreement • March 25th, 2024 • Sutro Biopharma, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 25th, 2024 Company Industry JurisdictionThis MANUFACTURING RIGHTS AGREEMENT (this “Agreement”), effective as of the Effective Date, is entered into by and between Vaxcyte, Inc., a Delaware corporation (“Vaxcyte”) and Sutro Biopharma, Inc., a Delaware corporation (“Sutro”) (each of Vaxcyte and Sutro, a “Party,” and collectively, the “Parties”).